2023-12-15T11:37:08-00:00 2023-07-31 990 2022-08-01 203620169 Partnership for Cures % Barbara Goodman PART 8477451246 134 N LaSalle Street STE 1130 Chicago IL 60602 Barbara Goodman CEO 8477451246 2023-11-30 false Barbara Goodman true AAL1 IAL1 2022 2023-04-26 12:10:37Z Cures Within Reach Barbara Goodman 134 N LaSalle Street STE 1130 Chicago IL 60602 2287427 false X www.cureswithinreach.org 2005 IL To help patients by raising funds to find, vet, finance and manage pilot human clinical trials that test already approved drugs, devices and other products to deliver fast, safe and affordable treatments for both common 9 9 3 71 0 1395438 2067538 0 7403 106759 84219 32393 1487060 2206690 546228 812441 0 332993 363312 0 42570 150824 121720 1030045 1297473 457015 909217 3472152 4575765 1125641 1332126 2346511 3243639 Cures Within Reach leverages the speed, safety and cost-effectiveness of testing approved therapies for new indications/diseases without effective treatment driving more treatments to more patients more quickly. false false 1147898 812440 Repurposing research In its main area of focus, the organization catalyzes clinical trials testing approved therapies by finding and facilitating these proof-of-concept clinical trials that, when successful, catalyze follow-on funding for further trials and publications in order to allow broad patient use. In FY 2023 14 new or expanded clinical trials were signed in rare diseases, ear nose throat, neurology and oncology 7 trials were completed or closed in oncology, rare diseases, neurology, and ear nose throat and 37 trials were still in progress - for a total of 44 ongoing trials as of 7/31/23. 1147898 true true false false false false false false false false true false false false false false true false false false true true false false true false false true false true false false false false false false false false false false false false false false false false false true 8 0 true 3 true false false false false false true true false false false false false false X 9 9 false false false false false false false true true false false true true true true true true true false false X Barbara Goodman 8477451246 134 N LaSalle Str Chicago IL 60602 Barbara Goodman President CEO 040.00 X 183750 0 3675 Margaret Christie Chair 002.00 X X 0 0 0 Lucy Mancini-Newell Secretary 001.00 X X 0 0 0 Matthew Rich Treasurer 001.00 X X 0 0 0 Kristina Allikmets Director 001.00 X 0 0 0 Steve Braun Director 001.00 X 0 0 0 Nick Manusos Director 001.00 X 0 0 0 Robert Metz Director 001.00 X 0 0 0 David Styler Director 001.00 X 0 0 0 Nancy Sullivan Director 001.00 X 0 0 0 183750 3675 1 false true false 2067538 2067538 106218 106218 62059 61518 541 541 541 51612 19219 32393 32393 2206690 139152 662461 662461 0 149980 149980 0 183750 129506 34553 19691 0 139786 98839 26211 14736 0 17428 12636 3311 1481 22348 15895 4168 2285 13146 8022 5124 3187 2391 637 159 20413 15309 4083 1021 0 0 0 4716 3078 879 759 0 21574 1637 19777 160 0 36450 27337 7290 1823 0 0 3683 3548 135 0 0 2272 2158 57 57 3592 2694 718 180 Program development 11478 11478 Other 1209 929 197 83 0 1297473 1147898 107005 42570 2536867 1117346 125337 433333 3844 1795 3139 1570 2197 1569 799253 2986306 1645 3009 35416 3472152 4575765 20651 23721 1104990 1308405 1125641 1332126 X 693470 881895 1653041 2361744 2346511 3243639 3472152 4575765 909217 -12464 375 X false true X false false X 1050699 1028934 1958632 1395438 2067538 7501241 1050699 1028934 1958632 1395438 2067538 7501241 4329603 3171638 24824 26560 6734 7403 106218 171739 7672980 0.41340 0.47940 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false 3139 1570 1569 1569 Financial derivatives and other financial products Closely-held equity interests Federal income taxes 2100306 375 375 2099931 106759 106759 2206690 1297473 1297473 1297473 XI 4b Investment income included in Form 990, reported under Non-operating activities on audit report. false South Asia Support clinical trial/medical research 49962 Sub-Saharan Africa Support clinical trial/medical research 50000 Europe Including Iceland and Greenland Support clinical trial/medical research 50018 Sub-Saharan Africa Support clinical trial/medical research 49774 4 Part II Line 1e Grants are reported on the accrual basis, the accounting method used by the organizations financial statements. CY23 Golf Fundraiser 45799 45799 16140 2926 Bobby Miller Golf 5813 5813 153 51612 51612 16140 3079 19219 32393 true Advocate Aurora Health Inc 960 North 12th Str Milwaukee WI 53233 391442285 501c3 40000 To support clinical trials/medical research Children's National Medical Center 111 Michigan Ave Washington DC 20010 521654453 501c3 66000 To support clinical trials/medical research City of Hope 1500 E Durate Rd Duarte CA 91010 953435919 501c3 26228 To support clinical trials/medical research Emory University 1599 Clifton Rd Atlanta GA 30322 580566256 501c3 60000 To support clinical trials/medical research University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd Houston TX 77030 746001118 501c3 60000 To support clinical trials/medical research Rhode Island Hospital 167 Point Str Providence RI 02903 050258954 501c3 56000 To support clinical trials/medical research The University of Chicago 6054 S Drexel Ave Chicago IL 60637 362177139 501c3 82000 To support clinical trials/medical research The Regents of the University of CA 490 Illinois Str San Francisco CA 94143 946036493 501c3 71000 To support clinical trials/medical research The Board of Trustees of the University of IL 28395 Network Pl Chicago IL 60673 376000511 501c3 65400 To support clinical trials/medical research University of NC at Chapel Hill 104 Airport Rd Chapel Hill NC 275992210 566001393 501c3 67000 To support clinical trials/medical research University of Pittsburgh 3420 Forbes Ave Pittsburgh PA 15260 250965591 501c3 60000 To support clinical trials/medical research 11 Part I Line 2 Nearly all of our funded research agreement recipients are obligated per the signed agreement to provide our organization with semi-annual research progress reports and financial reports, Only on rare occasions are mandatory reports annual. Upon completion, final reports must be submitted as well as follow-on reporting. Part II Line 1 d Grants are reported on the accrual basis, the accounting method used by the organizations financial statements. X X false false false false false false false false false Barbara Goodman President CEO 175000 8750 3675 187425 Form 990, Part I, Line 1 and rare disorders without effective treatment. Form 990, Part VI, Section B, Line 11B The Form 990 is made available to the Board of Directors for review prior to filing with the Internal Revenue Service. Form 990, Part VI, Section B, Line 12C Annually, actual and potential conflicts of interest are reviewed. Form 990, Part VI, Section B, Line 15A Key employees compensation is reviewed annually using comparability data. Form 990, Part VI, Section C, Line 19 The Organization makes certain of its documents, policies and financial statements available to the public upon request.